myTomorrows
Ronald Plasterk is the Founder and CEO of Frame Cancer Therapeutics, a position held since January 2019. In addition, Ronald Plasterk serves as the Chief Scientific Officer (CSO) at myTomorrows since December 2017 and holds the title of Hoogleraar at Amsterdam UMC since September 2018. Ronald Plasterk has a PhD and has had a notable career in the scientific and healthcare sectors, contributing significantly to advancements in cancer therapeutics and research.
This person is not in any teams
This person is not in any offices